Researchers examined data from four different randomized control trials.
Researchers reported "significant improvements" in patients after one year.
Post-TAVR high-degree atrioventricular block and complete heart block often lead to the implantation of a permanent pacemaker.
The National Medical Products Administration reviewed data from more than 32,000 patients to make its decision.
It does increase certain risks, researchers found—but it can also be a valuable treatment option.
Imaging-based PAD may provide value as a noninvasive alternative to right heart catheterization.
No such trend was reported among patients with end-stage kidney disease.
Innovate Healthcare thanks our partners for supporting our newsletters.Sponsorship has no influence on editorial content.Interested in reaching our audiences, contact our team*|LIST:ADDRESSLINE|*You received this email because you signed up for newsletters from Innovate Healthcare.Change your preferences or unsubscribe hereContact Us | Unsubscribe from all | Privacy Policy© Innovate Healthcare, a TriMed Media brand